δ HGNC: HUGO Gene Nomenclature Committee. *: Manual or automatic handling involves selection of which of the ambiguous terms is truly a protein as well as which accessions are the ones referred to by a given term with multiple relevant accessions. The first option is treated using manual examination of the terms and assignment of relevant accessions if any. The latter option is managed automatically through detecting other terms in the abstract that may accurately describe the term of interest and un-resolved cases are then manually handled. Other steps not mentioned in the figure include network visualization through Cytoscape, and the scripts used to convert accessions from one form to another and communicate with different annotation databases. **: Possible variability in term include among others: singular vs. plural, multiple numbers or characters after the name indicating subunits, minor spelling errors like switching order of vowels, and presence or absence of slash/hyphen/brackets. Abbreviations in the absence of full terms were handled depending on context. In addition, proteins with lower frequency of occurrence in literature (less than 5 unique reports) are manually verified. Frequency is defined as the number of unique original reports (excluding reviews) reporting the corresponding protein.
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